| Brandon Shun, MD | |
|
2000 Ogden Ave, Aurora, IL 60504-5893 | |
| (866) 565-8607 | |
| (630) 898-3427 |
| Full Name | Brandon Shun |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2000 Ogden Ave, Aurora, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215553706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036162046 (Illinois) | Primary |
| 207Q00000X | Family Medicine | 125077121 (Illinois) | Secondary |
| Entity Name | Freeport Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447228788 PECOS PAC ID: 8426958232 Enrollment ID: O20040109000305 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes the growth of common lymphomas, thereby unveiling a potential new target in the fight against cancer.
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.
› Verified 2 days ago
| Entity Name | Rush-copley Medical Group Nfp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093075848 PECOS PAC ID: 7618864877 Enrollment ID: O20040310001029 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes the growth of common lymphomas, thereby unveiling a potential new target in the fight against cancer.
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.
› Verified 2 days ago
| Entity Name | Copley Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619466034 PECOS PAC ID: 4587656921 Enrollment ID: O20180530001537 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes the growth of common lymphomas, thereby unveiling a potential new target in the fight against cancer.
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Shun, MD 2020 Ogden Ave Ste 330, Aurora, IL 60504-5897 Ph: () - | Brandon Shun, MD 2000 Ogden Ave, Aurora, IL 60504-5893 Ph: (866) 565-8607 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF's partnership with Osiris for the development of a therapy for type 1 diabetes.
University of Pennsylvania researchers and their colleagues at the Wistar Institute and University of Oxford have discovered the molecular process by which the PAX5 protein, necessary for lymphocyte development, promotes the growth of common lymphomas, thereby unveiling a potential new target in the fight against cancer.
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Measurement of heart rate variability (HRV) is a useful method when assessing the role of the nervous system for heart function. Standard reference values for heart rate variability in adults have existed for a long time already, but similar values have not been available for children until now.
› Verified 2 days ago
Joseph Robert Rojas, Family Medicine Medicare: Medicare Enrolled Practice Location: 2020 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4850 Fax: 630-978-6865 | |
Jurate Kunickaite, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6859 | |
Daniel E Hrad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4205 Westbrook Dr, Aurora, IL 60504 Phone: 630-527-1818 Fax: 630-527-1244 | |
Aruna Galla-pagadala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Kuchipudi Veerraju, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 475 N Farnsworth Ave, Aurora Medical Clinic, Aurora, IL 60505 Phone: 630-898-0022 Fax: 630-898-2933 | |
Dr. Robert D. Paras, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2111 Ogden Ave, Aurora, IL 60504 Phone: 630-978-3800 Fax: 630-862-3085 | |
Dr. Mona Habiba Waheed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 |